Use of quality of life (QoL) tools in cancer patients may improve patient–physician communication and have the potential to improve care, but the tools are not currently widely used in clinical practice, in brain cancer or other cancer contexts. More research and stakeholder engagement is needed on how QoL tools can achieve the most impact.
An evaluation of the University College London Hospitals NHS Trust - Macmillan Cancer Support partnership aimed to assess the working of the partnership and its capacity to support the partners' plans to move forward.
We validated 3 colorectal cancer (CRC) microsimulation models against outcomes from the United Kingdom Flexible Sigmoidoscopy Screening (UKFSS) Trial, a randomized controlled trial that examined the effectiveness of one-time flexible sigmoidoscopy screening to reduce CRC mortality.
This study aimed to evaluate racial/ethnic differences in lung cancer incidence and mortality in the Women's Health Initiative Study, a longitudinal prospective cohort evaluation of postmenopausal women recruited from 40 clinical centers.
This study examines the synergies that exist between decision-analytic models and health care utilization data that are increasingly accessible through research networks that assemble data from the growing number of electronic medical record systems.